Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Drug delivery company Nutriband is conducting an offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock.
The offering is contingent upon the approval of Nutriband's application for listing on the Nasdaq under the ticker symbol NTRB.
The stock is currently listed on the Over-the-Counter Markets under the same symbol.
|Latest market close||$6.54|
|52-week range||$3.00 - $32.00|
|50-day moving average||$7.46|
|200-day moving average||$7.46|
|Wall St. target price||$24.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.51|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||-24.04%|
|1 month (2021-09-20)||-25.26%|
|3 months (2021-07-20)||-49.69%|
|6 months (2021-04-20)||-63.67%|
|1 year (2020-10-20)||-12.80%|
|2 years (2019-10-16)||N/A|
|3 years (2018-10-19)||7.1|
|5 years (2016-10-16)||N/A|
|Revenue TTM||$1.4 million|
|Gross profit TTM||$361,324|
|Return on assets TTM||-30.53%|
|Return on equity TTM||-72.7%|
|Market capitalisation||$51.7 million|
TTM: trailing 12 months
We're not expecting Nutriband IncCommon Stock to pay a dividend over the next 12 months.
You may also wish to consider:
Nutriband IncCommon Stock's shares were split on a 1:4 basis on 23 July 2019. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nutriband IncCommon Stock shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Nutriband IncCommon Stock shares which in turn could have impacted Nutriband IncCommon Stock's share price.
Over the last 12 months, Nutriband IncCommon Stock's shares have ranged in value from as little as $3 up to $32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nutriband IncCommon Stock's is -1.1716. This would suggest that Nutriband IncCommon Stock's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Nutriband IncCommon Stock has bucked the trend.
To put Nutriband IncCommon Stock's beta into context you can compare it against those of similar companies.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.